GSDMD and hepatocellular carcinoma: Studies analyzing RNA expression, prognosis, and immune infiltration of gasdermin D (GSDMD) in HCC indicate that GSDMD is both a prognostic marker and a potential therapeutic target for HCC (6, 9).